Safety and Efficacy of FT218 in Idiopathic Hypersomnia (REVITALYZ)

Clinical trial NCT06525077 · COMPLETED

Trial details

NCT number: NCT06525077
Sponsor: Avadel
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Idiopathic Hypersomnia

Start date: 2024-08-01
Primary completion: 2026-03-25
Enrollment: 157

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.